Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes

Cell Death and Differentiation

Volumn 19, Issue 6, 2012, Pages 1003-1012

  Ferland Mccollough, D ^a   Fernandez Twinn, D S ^b   Cannell, I G ^c   David, H ^c   Warner, M ^b   Vaag, A A ^d   Bork Jensen, J ^d   Brons C ^d   Gant, T W ^a   Willis, A E ^a   Siddle, K ^b   Bushell, M ^a   Ozanne, S E ^b  

^a MRC TOXICOLOGY UNIT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

GDF3; Maternal diet; MicroRNA; MiR 483; Nutritional programming; Translational control

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 3; INSULIN; MICRORNA 483 3P; RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CELL STRAIN HEK293; DEVELOPMENT; DISEASE PREDISPOSITION; EMBRYO; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID STORAGE; LIPOTOXICITY; LOW BIRTH WEIGHT; MALE; MATERNAL NUTRITION; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RESTRICTION; PROTEIN TARGETING; RAT; UPREGULATION;

3' UNTRANSLATED REGIONS; ADIPOSE TISSUE; ADULT; ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; DIET; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GROWTH DIFFERENTIATION FACTOR 3; HEK293 CELLS; HUMANS; LIPID METABOLISM; MALE; MICRORNAS; RATS; RATS, WISTAR; RNA INTERFERENCE; RNA, SMALL INTERFERING;

MAMMALIA; RATTUS;

EID: 84860729566     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.183     Document Type: Article

References (40)

1. Fernandez-Twinn DS, Ozanne SE. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006; 88: 234-243.
2. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008; 359: 61-73.
3. Ozanne SE, Constancia M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab 2007; 3: 539-546.
4. Ozanne SE, Dorling MW, Wang CL, Nave BT. Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats. Am J Physiol Endocrinol Metab 2001; 280: E534-E539.
5. Ozanne SE, Olsen GS, Hansen LL, Tingey KJ, Nave BT, Wang CL et al. Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 2003; 177: 235-241.
6. Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD. Poor fetal nutrition causes long-term changes in expression of insulin signaling components in adipocytes. Am J Physiol 1997; 273: E46-E51.
7. Ozanne SE, Jensen CB, Tingey KJ, Martin-Gronert MS, Grunnet L, Brons C et al. Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight: potential link to increased risk of diabetes? Diabetologia 2006; 49: 2993-2999.
8. Meas T. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue? Diabetes Metab 2010; 36: 11-20.
9. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-349.
10. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655.
11. Le Quesne JP, Spriggs KA, Bushell M, Willis AE. Dysregulation of protein synthesis and disease. J Pathol 2010; 220: 140-151.
12. Krutzfeldt J, Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 2006; 4: 9-12.
13. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H et al. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 2008; 376: 728-732.
14. Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets 2011; 15: 623-636.
15. Herrera BM, Lockstone HE, Taylor JM, Ria M, Barrett A, Collins S et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 2010; 53: 1099-1109.
16. Ferland-McCollough D, Ozanne SE, Siddle K, Willis AE, Bushell M. The involvement of microRNAs in Type 2 diabetes. Biochem Soc Trans 2010; 38: 1565-1570.
17. Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA. Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 2005; 48: 547-552.
18. Petry CJ, Dorling MW, Pawlak DB, Ozanne SE, Hales CN. Diabetes in old male offspring of rat dams fed a reduced protein diet. Int J Exp Diabetes Res 2001; 2: 139-143.
19. Palsgaard J, Brons C, Friedrichsen M, Dominguez H, Jensen M, Storgaard H et al. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS One 2009; 4: e6575.
20. Vaag A, Jensen CB, Poulsen P, Brons C, Pilgaard K, Grunnet L et al. Metabolic aspects of insulin resistance in individuals born small for gestational age. Horm Res 2006; 65 (Suppl 3): 137-143.
21. Andersson O, Korach-Andre M, Reissmann E, Ibanez CF, Bertolino P. Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 2008; 105: 7252-7256.
22. Shen JJ, Huang L, Li L, Jorgez C, Matzuk MM, Brown CW. Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Mol Endocrinol 2009; 23: 113-123.
23. Schulz TJ, Tseng YH. Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev 2009; 20: 523-531.
24. Zamani N, Brown CW. Emerging Roles for the Transforming Growth Factor-{beta} Superfamily in Regulatin. Endocr Rev 2011; 32: 387-403.
25. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27: 91-105.
26. Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA, Burdge GC. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr 2008; 100: 278-282.
27. Sandovici I, Smith NH, Nitert MD, Ackers-Johnson M, Uribe-Lewis S, Ito Y et al. Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl Acad Sci USA 2011; 108: 5449-5454.
28. Erhuma A, Salter AM, Sculley DV, Langley-Evans SC, Bennett AJ. Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat. Am J Physiol Endocrinol Metab 2007; 292: E1702-E1714.
29. Fraser A, Ebrahim S, Smith GD, Lawlor DA. The associations between birthweight and adult markers of liver damage and function. Paediatr Perinat Epidemiol 2008; 22: 12-21.
30. Wang W, Yang Y, Meng Y, Shi Y. GDF-3 is an adipogenic cytokine under high fat dietary condition. Biochem Biophys Res Commun 2004; 321: 1024-1031.
31. Fu H, Tie Y, Xu C, Zhang Z, Zhu J, Shi Y et al. Identification of human fetal liver miRNAs by a novel method. FEBS Lett 2005; 579: 3849-3854.
32. Murrell A, Heeson S, Reik W. Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat Genet 2004; 36: 889-893.
33. Zhang J, Zhang F, Didelot X, Bruce KD, Cagampang FR, Vatish M et al. Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring. BMC Genomics 2009; 10: 478.
34. Nielsen FC. The molecular and cellular biology of insulin-like growth factor II. Prog Growth Factor Res 1992; 4: 257-290.
35. Veronese A, Visone R, Consiglio J, Acunzo M, Lupini L, Kim T et al. Mutated {beta}-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci USA 2011; 108: 4840-4845.
36. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
37. Fernandez-Twinn DS, Ozanne SE, Ekizoglou S, Doherty C, James L, Gusterson B et al. The maternal endocrine environment in the low-protein model of intra-uterine growth restriction. Br J Nutr 2003; 90: 815-822.
38. Snoeck A, Remacle C, Reusens B, Hoet JJ. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 1990; 57: 107-118.
39. Brons C, Jacobsen S, Nilsson E, Ronn T, Jensen CB, Storgaard H et al. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab 2010; 95: 3048-3056.
40. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581.